FDA Draft Guidance (Withdrawn): Premarket Notification Submissions for Automated Testing Instruments Used In Blood Establishments, 8/01

$0.00

August, 2001 CBER draft guidance regarding automated instrument functional requirements, design, development, hazard analyses, validation, change control, and configuration management.

NOTE: The FDA withdrew this draft guidance in June, 2005